An Open Label Study of an Occlusive Heat Patch in the Treatment of Warts
Antaya, R.J..; del Carmen, M.; Alonso, F.; Sukumar, N.; Yong, F.; Dvoretzky, I.
Journal of Drugs in Dermatology Jdd 18(4): 368-373
2019
ISSN/ISBN: 1545-9616 PMID: 31012566 Document Number: 17766
Background: Local hyperthermia has been demonstrated to be a safe and efficacious treatment for warts.
Document emailed within 1 workday
Related Documents
Zhang, C.; Li, H.; Xiong, X.; Zhai, S.; Wei, Y.; Zhang, S.; Zhang, Y.; Xu, L.; Liu, L. 2017: An open-label, two-period comparative study on pharmacokinetics and safety of a combined ethinylestradiol/gestodene transdermal contraceptive patch Drug Design Development and Therapy 11: 725-731Wiegratz, I.; Bassol, S.; Weisberg, E.; Mellinger, U.; Merz, M. 2014: Effect of a low-dose contraceptive patch on efficacy, bleeding pattern, and safety: a 1-year, multicenter, open-label, uncontrolled study Reproductive Sciences 21(12): 1518-1525
Höchel, J.; Schuett, B.; Ludwig, M.; Zurth, C. 2014: Implications of different application sites on the bioavailability of a transdermal contraceptive patch containing ethinyl estradiol and gestodene: an open-label, randomized, crossover study International Journal of Clinical Pharmacology and Therapeutics 52(10): 856-866
Heger-Mahn, D.; Warlimont, C.; Faustmann, T.; Gerlinger, C.; Klipping, C. 2004: Combined ethinylestradiol/gestodene contraceptive patch: two-center, open-label study of ovulation inhibition, acceptability and safety over two cycles in female volunteers European Journal of Contraception and Reproductive Health Care: the Official Journal of the European Society of Contraception 9(3): 173-181
Wanichwecha-Rungruang, B.; Iemsomboon, W. 2005: Efficacy and safety of bimatoprost for the treatment of open-angle glaucoma and ocular hypertension: a three-month, open-label study in community-based practices in Thailand Journal of the Medical Association of Thailand 88(9): 1228-1235
Zimmerman, M.; Breen, R.B.; Posternak, M.A. 2002: An open-label study of citalopram in the treatment of pathological gambling Journal of Clinical Psychiatry 63(1): 44-48
Grant, J.E.; Odlaug, B.L.; Mooney, M.; O'Brien, R.; Kim, S.W. 2012: Open-label pilot study of memantine in the treatment of compulsive buying Annals of Clinical Psychiatry: Official Journal of the American Academy of Clinical Psychiatrists 24(2): 119-126
Gold, M.H.; Bridges, T.; Avakian, E.V.; Plaum, S.; Fleischer, A.B.; Hardas, B. 2012: An open-label pilot study of naftifine 1% gel in the treatment of seborrheic dermatitis of the scalp Journal of Drugs in Dermatology: Jdd 11(4): 514-518
Abuchar, A.; Vitiello, M.; Ricotti, C.; Grant, A.; Dehesa, L.; Kerdel, F. 2012: Open label study to evaluate the efficacy of re-treatment with etanercept in patients with psoriasis Journal of Drugs in Dermatology: Jdd 11(8): 950-954
Dykstra, D.D.; Presthus, J. 2006: Botulinum toxin type A for the treatment of provoked vestibulodynia: an open-label, pilot study Journal of Reproductive Medicine 51(6): 467-470
Elewski, B.E.; Cantrell, W.C. 2011: An open-label study of the safety and efficacy of sertaconazole nitrate in the treatment of seborrheic dermatitis Journal of Drugs in Dermatology: Jdd 10(8): 895-899
Barba, A.R.; Kapoor, S.; Berman, B. 2001: An open label safety study of topical imiquimod 5% cream in the treatment of Molluscum contagiosum in children Dermatology Online Journal 7(1): 20
Fearon, K.C.; Falconer, J.S.; Ross, J.A.; Carter, D.C.; Hunter, J.O.; Reynolds, P.D.; Tuffnell, Q. 1996: An open-label phase I/Ii dose escalation study of the treatment of pancreatic cancer using lithium gammalinolenate Anticancer Research 16(2): 867-874
Cohen, J.L.; Dayan, S.H. 2006: Botulinum toxin type a in the treatment of dermatochalasis: an open-label, randomized, dose-comparison study Journal of Drugs in Dermatology: Jdd 5(7): 596-601
Tankova, T.; Koev, D.; Dakovska, L. 2004: Alpha-lipoic acid in the treatment of autonomic diabetic neuropathy (controlled, randomized, open-label study) Romanian Journal of Internal Medicine 42(2): 457-464
Kircik, L.H.; Tropmann, C. 2011: Treatment of mild-to-moderate chronic hand dermatitis with clobetasol propionate 0.05% EF foam: results from an open-label study Journal of Drugs in Dermatology: Jdd 10(12): 1398-1402
Krairittichai, U.; Mahannopkul, R.; Bunnag, S. 2012: An open label, randomized controlled study of oral calcitriol for the treatment of proteinuria in patients with diabetic kidney disease Journal of the Medical Association of Thailand 95(Suppl 3): S41-S47
Draelos, Z.ë D.; Feldman, S.R.; Butners, V.; Alió Saenz, A.B. 2013: Long-term safety of ketoconazole foam, 2% in the treatment of seborrheic dermatitis: results of a phase IV, open-label study Journal of Drugs in Dermatology: Jdd 12(1): E1-E6
Koo, J.Y.M.; Bagel, J.; Sweetser, M.T.; Ticho, B.S. 2006: Alefacept in combination with ultraviolet B phototherapy for the treatment of chronic plaque psoriasis: results from an open-label, multicenter study Journal of Drugs in Dermatology: Jdd 5(7): 623-628
Godfrey, K.E.; Muthukumaraswamy, S.D.; Stinear, C.M.; Hoeh, N.R. 2019: An open-label feasibility study of repetitive transcranial magnetic stimulation (rTMS) for treatment-resistant depression in the New Zealand healthcare context New Zealand Medical Journal 132(1504): 46-55